Climb Bio (CLYM) Short-term Investments (2021 - 2026)
Climb Bio's Short-term Investments was $139.02 million in Q2 2026, up 124.1% from $62.02 million a year earlier and up 37.4% from the prior quarter.
Powered by 
Analysis
Climb Bio (CLYM) Short-term Investments (2021 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Climb Bio came in at $65.4 million, up 2.7% from FY2024.
- Short-term Investments shows a four-year compound annual growth rate of -7.6% (FY2021 to FY2025).
- In earlier years, Short-term Investments was $63.69 million in FY2024 (+365.4%), $13.69 million in FY2023 (-82.9%), $79.98 million in FY2022 (-10.7%) and $89.56 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Short-term Investments in data going back to Q3 2021.
- Compared with a year earlier, Short-term Investments has increased for four straight quarters, with growth averaging 93.7% over the last six quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q4 2024 (growth of 365.4%); the worst was Q4 2023 (a decline of 82.9%).
- Per Business Quant data, CLYM's Short-term Investments in the three quarters before Q2 2026 was $101.21 million (Q1 2026), $65.4 million (Q4 2025) and $61.1 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Climb Bio | 800.38 Mn | 319.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 139.02 Mn |
| Mar 31, 2026 | 101.21 Mn |
| Dec 31, 2025 | 65.40 Mn |
| Sep 30, 2025 | 61.10 Mn |
| Jun 30, 2025 | 62.02 Mn |
| Mar 31, 2025 | 69.04 Mn |
| Dec 31, 2024 | 63.69 Mn |
| Sep 30, 2024 | 47.18 Mn |
| Dec 31, 2023 | 13.69 Mn |
| Sep 30, 2023 | 50.08 Mn |
| Jun 30, 2023 | 77.34 Mn |
| Mar 31, 2023 | 74.94 Mn |
| Dec 31, 2022 | 79.98 Mn |
| Sep 30, 2022 | 86.68 Mn |
| Jun 30, 2022 | 90.35 Mn |
| Mar 31, 2022 | 92.01 Mn |
| Dec 31, 2021 | 89.56 Mn |
| Sep 30, 2021 | 83.20 Mn |
API Access
Climb Bio Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=CLYM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "CLYM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=CLYM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();